Richard P. Carlson - Concepedia

Author

Richard P. Carlson

Also Known As

, Arndt Arnim, M Allen, R P Carlson, R. P. CARLSON, R. P. Carlson, R.P Carlson, R.P. CARLSON, R.P. Carlson, RICHARD P. CARLSON

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Princeton University Experimental Pathology Laboratories Abbott Fund Wyle (United States)

About

Richard P. Carlson is an author at Princeton University specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.3K
2	Allergy	7	7	470
3	Biochemistry	7	7	295
4	Natural Sciences	4	4	95
5	Health Sciences	2	2	32

Richard P. Carlson

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents Richard P. Carlson, O'Neill-Davis Lynn, Joseph Chang, Inflammation Research Molecular PharmacologyOther Pharmacologic AgentsAllergyMouse Ear EdemaMedicine	1985	309
Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1 Keith B. Glaser, Mei-Li Sung, Kim O’Neill, European Journal of Pharmacology Molecular PharmacologyMolecular PhysiologyBiochemistryG Protein-coupled ReceptorMedicine	1995	149
INHIBITORY EFFECTS OF INDOMETHACIN, ASPIRIN AND CERTAIN OTHER DRUGS ON INFLAMMATIONS INDUCED IN RAT AND DOG BY CARRAGEENAN, SODIUM URATE AND ELLAGIC ACID C. G. Van Arman, Richard P. Carlson, Edwin A. Risley, Journal of Pharmacology and Experimental Therapeutics	1970	57
Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis Joseph Chang, Richard P. Carlson, Lynn O’Neill-Davis, Inflammation InflammationAnti-inflammatoryAutoimmune DiseaseAtopic DermatitisMedicine	1986	56
Effects of Orally Administered Rapamycin in Animal Models of Arthritis and Other Autoimmune Diseases Richard P. Carlson, William L. Baeder, Robert Caccese, Annals of the New York Academy of Sciences InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	1993	55
A new spin on an old model: In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat Peer B. Jacobson, Sheryl J. Morgan, Denise M. Wilcox, Arthritis & Rheumatism	1999	51
N-[(Arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure JOHN H. MUSSER, Anthony F. Kreft, Reinhold H. W. Bender, Journal of Medicinal Chemistry Pharmaceutical ScienceHydroxamic AcidsPharmacotherapyLtd4-induced ContractionMolecular Pharmacology	1990	48
Bacterial lipopolysaccharide potentiates type II collagen‐induced arthritis in mice Robert Caccese, John Zimmerman, Richard P. Carlson Mediators of Inflammation Cia MiceImmunologyType IiInflammatory ArthritisInflammation	1992	48
Rapamycin, a potential disease-modifying antiarthritic drug. Richard P. Carlson, David A. Hartman, L A Tomchek, Journal of Pharmacology and Experimental Therapeutics	1993	48
Effect of selected antiinflammatory agents and other drugs on zymosan, arachidonic acid, PAF and carrageenan induced paw edema in the mouse William J. Calhoun, Jennifer Y. Chang, Richard P. Carlson Inflammation Research InflammationAnti-inflammatoryAllergyPharmacological StudyMedicine	1987	46

Page 1